To further understand the involvement of mGlu5 in the hippocampus of AD, we evaluated changes in their expression and distribution in the APP/PS1 model of AD using immunoblots, histoblots and high-resolution immunohistochemical techniques in combination with quantitative approaches. The gene discussed is GRM5; the disease is Alzheimer disease.